Want to see IN:ARTEMISMED full AI Analyst Report?
ARTEMISMED Stock Chart & Stats
₹276.20
₹1.60(0.48%)
At close: 4:00 PM EST
₹276.20
₹1.60(0.48%)
Day’s Range― - ―
52-Week Range₹202.85 - ₹297.70
Previous CloseN/A
Volume93.41K
Average Volume (3M)16.54K
Market Cap
₹41.22B
Enterprise Value₹42.30B
Total Cash (Recent Filing)₹3.48B
Total Debt (Recent Filing)₹2.79B
Price to Earnings (P/E)37.1
Beta1.11
Next Earnings
Aug 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.16%
Share Statistics
EPS (TTM)6.30
Shares Outstanding158,306,240
10 Day Avg. Volume28,644
30 Day Avg. Volume16,535
Financial Highlights & Ratios
PEG Ratio1.41
Price to Book (P/B)3.47
Price to Sales (P/S)3.00
P/FCF Ratio100.85
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)9.8
Revenue Forecast (FY)₹13.15B
Bulls Say, Bears Say
Bulls Say
Revenue & Profit GrowthSustained multi-year revenue expansion and a marked rise in net margin signal durable demand and improving unit economics across the hospital network. This strengthens earnings power, funds reinvestment in services and capacity, and underpins medium-term growth resilience.
Improved Leverage ProfileMeaningful reduction in leverage materially lowers financial risk and increases strategic flexibility. A healthier debt/equity ratio improves the company’s ability to withstand cyclical shocks, pursue selective expansion, and secure better financing terms over the next several quarters.
Positive Operating Cash Flow TrendConsistently positive and growing operating cash flow supports core operations and capital requirements without relying solely on external financing. That persistent OCF base enhances the company’s capacity to fund capex, service debt, and sustain investments in clinical capabilities.
Bears Say
Volatile Free Cash Flow & Weaker Cash ConversionUneven free cash flow and recent deterioration in cash conversion pose a structural risk to funding flexibility. If FCF remains volatile, it could constrain ability to deleverage, invest in growth or return capital, increasing sensitivity to operational disruptions over coming quarters.
Margin Pressure And Cost VolatilityA material slip in gross margin after a peak suggests rising cost pressures or constrained pricing power. Persistent margin volatility can erode the recent profitability gains and makes long-term margin sustainability dependent on operational efficiency or pricing improvements.
Sizable Absolute Debt LevelAlthough leverage ratios improved, carrying roughly 2.6B of debt requires stable earnings and cash conversion to service obligations. High absolute debt increases refinancing and interest-rate risk and limits capital allocation flexibility if cash generation weakens.
Artemis Medicare Services Ltd. News
ARTEMISMED FAQ
What was Artemis Medicare Services Ltd.’s price range in the past 12 months?
Artemis Medicare Services Ltd. lowest stock price was ₹202.85 and its highest was ₹297.70 in the past 12 months.
What is Artemis Medicare Services Ltd.’s market cap?
Artemis Medicare Services Ltd.’s market cap is ₹41.22B.
When is Artemis Medicare Services Ltd.’s upcoming earnings report date?
Artemis Medicare Services Ltd.’s upcoming earnings report date is Aug 06, 2026 which is in 31 days.
How were Artemis Medicare Services Ltd.’s earnings last quarter?
Artemis Medicare Services Ltd. released its earnings results on May 08, 2026. The company reported ₹1.9 earnings per share for the quarter, beating the consensus estimate of N/A by ₹1.9.
Is Artemis Medicare Services Ltd. overvalued?
According to Wall Street analysts Artemis Medicare Services Ltd.’s price is currently Overvalued.
Does Artemis Medicare Services Ltd. pay dividends?
Artemis Medicare Services Ltd. pays a Annually dividend of ₹0.45 which represents an annual dividend yield of 0.16%. See more information on Artemis Medicare Services Ltd. dividends here
What is Artemis Medicare Services Ltd.’s EPS estimate?
Artemis Medicare Services Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Artemis Medicare Services Ltd. have?
Artemis Medicare Services Ltd. has 158,306,240 shares outstanding.
What happened to Artemis Medicare Services Ltd.’s price movement after its last earnings report?
Artemis Medicare Services Ltd. reported an EPS of ₹1.9 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.282%.
Which hedge fund is a major shareholder of Artemis Medicare Services Ltd.?
Currently, no hedge funds are holding shares in IN:ARTEMISMED
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Artemis Medicare Services Ltd.
Artemis Medicare Services Limited engages in the management and operation of multi-specialty hospitals in India and internationally. The company provides medical and surgical intervention, and inpatient and outpatient services. It also offers billing and insurance, childcare, emotional and support program, full body checkup, international patient, medical interpreter and record, mind body medicine, nursing, nutrition, patient and family advisory, patient advocacy and portal, pre-admission testing, and smoking cessation program services, as well as home care services. Artemis Medicare Services Limited was incorporated in 2004 and is based in Gurugram, India.
Technical Analysis
Fortis Healthcare Ltd.
―
Indraprastha Medical Corporation Limited
―
Krishna Institute of Medical Sciences Limited
―
Metropolis Healthcare Ltd.
―
Shalby Ltd.
―